OraSure Technologies Inc.Find Ratings Reports
ORASURE TECHNOLOGIES INC's gross profit margin for the fourth quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ORASURE TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 6.16 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has greatly increased by 38.86% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY17||Q4 FY16|
|Net Sales ($mil)||52.03||35.5|
|Net Income ($mil)||7.32||7.2|
|Balance Sheet||Q4 FY17||Q4 FY16|
|Cash & Equiv. ($mil)||155.9||120.95|
|Total Assets ($mil)||296.2||207.94|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q4 FY17||Q4 FY16|
|Gross Profit Margin||58.31||71.67|
|Return on Assets||10.44||9.48|
|Return on Equity||11.99||10.61|
|Debt||Q4 FY17||Q4 FY16|
|Share Data||Q4 FY17||Q4 FY16|
|Shares outstanding (mil)||60.63||56.0|
|Div / share||0.0||0.0|
|Book value / share||4.26||3.32|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||649806.0||997573.0|
BUY. This stock's P/E ratio indicates a significant discount compared to an average of 113.83 for the Health Care Equipment & Supplies industry and a premium compared to the S&P 500 average of 25.58. To use another comparison, its price-to-book ratio of 4.22 indicates a premium versus the S&P 500 average of 3.27 and a discount versus the industry average of 5.62. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, ORASURE TECHNOLOGIES INC proves to trade at a discount to investment alternatives within the industry.
|OSUR 35.25||Peers 113.83||OSUR NA||Peers 45.47|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
OSUR is trading at a significant discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|OSUR 36.69||Peers 31.81||OSUR NM||Peers 0.76|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
OSUR is trading at a significant premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
OSUR's negative PEG ratio makes this valuation measure meaningless.
|OSUR 4.22||Peers 5.62||OSUR 45.71||Peers 1.68|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
OSUR is trading at a discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
OSUR is expected to have an earnings growth rate that significantly exceeds its peers.
|OSUR 6.53||Peers 5.97||OSUR 30.31||Peers 17.31|
Average. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
OSUR is trading at a valuation on par with its industry on this measurement.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
OSUR has a sales growth rate that significantly exceeds its peers.